Cancer Check Labs Expands Early Detection Cancer Testing to Pennsylvania, Maryland, and Rhode Island

Revolutionary Blood Test Now Available to More Patients, Detecting Tumor-Based Cancers as Early as Stage 0.

DALLAS, Feb. 20, 2025 /PRNewswire/ -- Cancer Check Labs, a leader in early cancer detection, is proud to announce its expansion into Pennsylvania, Maryland, and Rhode Island, furthering its mission to make early detection cancer screening accessible to more communities across the United States.

With this expansion, residents in these three states can now access Cancer Check Labs' innovative, comprehensive blood test, capable of detecting tumor-based cancers as early as Stage 0—often before any symptoms arise. This cutting-edge test offers unparalleled accuracy, giving individuals and healthcare providers a critical tool in the fight against cancer.

"We are excited to continue our growth and bring our early detection services to Pennsylvania, Maryland, and Rhode Island expanding our availability to all continental United States except New York," said Sumit Rai, CEO & Founder of Cancer Check Labs. "Our mission is to empower patients with the knowledge they need to take control of their health, and expanding into these new regions brings us one step closer to a world where cancer is detected early and treated more effectively."

The Power of Early Detection

Early cancer detection improves survival rates and treatment outcomes. Cancer Check Labs' comprehensive blood test offers:

• Early Stage Detection: Identifies tumor-based cancers at their earliest stages, including Stage 0.
• Non-Invasive & Simple Testing: A quick and easy blood draw with fast, accurate results.
• Peace of Mind: Patients gain clarity about their health, allowing for timely intervention if needed.

Continued Growth & Accessibility
This expansion is part of Cancer Check Labs' broader strategy to make early detection accessible nationwide. By partnering with healthcare providers and wellness organizations, more people can benefit from this transformative technology.

Healthcare providers and organizations in Maryland, Pennsylvania, and Rhode Island interested in offering the Cancer Check Labs test can reach out for partnership opportunities here.

About Cancer Check Labs
Cancer Check Labs is on a mission to save lives through early detection. Cancer Check is a test that can screen for 200+ cancers by physically extracting whole, intact circulating tumor cells (CTCs) from a blood sample. Because CTCs have been detected in blood samples as early as Stage 0, Cancer Check arguably provides the earliest cancer detection test available today. Cancer Check Labs is headquartered in Dallas, TX.

Contact:
Sumit Rai
2144490531
390524@email4pr.com

View original content:https://www.prnewswire.com/news-releases/cancer-check-labs-expands-early-detection-cancer-testing-to-pennsylvania-maryland-and-rhode-island-302381395.html

SOURCE Cancer Check Labs